Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients
Baia, L. C. [UNIFESP]
Van den Berg, E.
Vervloet, M. G.
Heilberg, I. P. [UNIFESP]
Bakker, S. J. L.
Geleijnse, J. M.
Soedamah-Muthu, S. S.
De Borst, M. H.
Is part ofNutrition Metabolism and Cardiovascular Diseases
MetadataShow full item record
Background and aims: A high circulating fibroblast growth factor 23 (FGF23) level is an independent risk factor for cardiovascular mortality in renal transplant recipients and the general population. N-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) may contribute to cardiovascular risk reduction. We investigated whether fish and EPA-DHA intake are related to FGF23 levels in renal transplant recipients.Methods and results: We performed a cross-sectional analysis in 619 stable renal transplant recipients (mean age 53 years, 57% male, estimated glomerular filtration rate [eGFR] 53 +/- 20 mL/min/1.73 m(2)). Dietary intake was assessed by a 177-item food frequency questionnaire. Serum intact FGF23 was measured by ELISA. We examined differences in FGF23 levels across categories of fish and EPA-DHA intake using analysis of variance models adjusted for age, sex, dietary and lifestyle factors and key determinants of FGF23. Patients consumed on average 15 g of fish and 139 mg EPA-DHA/day. Median FGF23 was 62 pg/mL (IQR 43-98 pg/mL). Higher dietary EPA-DHA and fish intake were associated with lower serum FGF23 levels. Subgroup analyses revealed that particularly in patients with reduced renal function (eGFR <60 mL/min/1.73 m(2)), adjusted FGF23 levels (114, 79, 75 pg/mL, P = 0.0001) were inversely associated with tertiles of EPA-DHA intake. Similarly, we observed an inverse association between fish consumption and serum FGF23 levels in adjusted analyses.Conclusion: A higher intake of fish and dietary n-3 fatty acids (EPA-DHA) is related to lower circulating FGF23 levels in renal transplant recipients. Further research is needed to assess the causality of this association and the clinical implications. (C) 2014 Elsevier B.V. All rights reserved.
CitationNutrition Metabolism and Cardiovascular Diseases. Oxford: Elsevier B.V., v. 24, n. 12, p. 1310-1316, 2014.
SponsorshipDutch Kidney Foundation (NIGRAM consortium)
Dutch Kidney foundation (MHdB)
University Medical Center Groningen (MHdB)
Netherlands Organization for Scientific Research (Veni grant)
Top Institute Food and Nutrition (EvdB)
Royal Netherlands Academy of Arts and Sciences
- Em verificação - Geral